Abstract
Matrix metalloproteinase-3 (MMP-3) degrades the extracellular matrix and may contribute to the weakening of the plaque cap. To determine whether genotype-phenotype associations differed in different categories of acute coronary syndrome, we enrolled 650 consecutive Taiwanese patients diagnosed with acute coronary syndrome. Genotypic analysis was done on DNA using polymerase chain reaction and direct sequencing on the 5 adenines (5A)/6 adenines (6A; -1,171 bp) polymorphism in the MMP-3 gene promoter region. The frequency of the 5A polymorphism was higher in patients with acute coronary syndrome, especially in those with ST-elevation myocardial infarction (p <0.01). The number of 5A allele polymorphisms was strongly associated with more complex coronary angiography (diffuse score for 5A/5A vs 5A/6A vs 6A/6A, 6.6 ± 1.2 vs 5.3 ± 1.3 vs 4.6 ± 1.1, all p values <0.05 in subgroup analysis) and higher plasma MMP-3 activity in this acute coronary syndrome cohort (MMP-3 level for 6A/6A vs 5A/6A vs 5A/5A, 21.0 ± 2.2 vs 23.3 ± 2.1 vs 27.9 ± 2.2 ng/ml, all p values <0.05 in subgroup analysis). Multiple logistic regression analysis showed that this polymorphism, in addition to hypertension, diabetes, and a history of smoking, was an independent risk factor (odds ratio 2.2, 95% confidence interval 1.1 to 4.3, p = 0.02) for the occurrence of acute coronary syndrome. Further, carriers of this polymorphism who smoked had a significantly increased (20-fold) risk of acute coronary syndrome compared with nonsmoking noncarriers. In conclusion, the MMP-3 5A/6A polymorphism is significantly associated with the occurrence of acute coronary syndrome, MMP-3 activity, and severity of coronary atherosclerosis. There is a synergistic effect between smoking and this genetic risk factor for acute coronary syndrome.
| Original language | English |
|---|---|
| Pages (from-to) | 1012-1017 |
| Number of pages | 6 |
| Journal | American Journal of Cardiology |
| Volume | 98 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 2006 Oct 15 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine
Cite this
}
Genotype-Phenotype Association of Matrix Metalloproteinase-3 Polymorphism and Its Synergistic Effect With Smoking on the Occurrence of Acute Coronary Syndrome. / Liu, Ping-Yen; Li, Yi-Heng; Chan, Shih-Hung; Lin, Li Jen; Wu, Hua-Lin; Shi, Guey Yueh; Chen, Jyh Hong.
In: American Journal of Cardiology, Vol. 98, No. 8, 15.10.2006, p. 1012-1017.Research output: Contribution to journal › Article
TY - JOUR
T1 - Genotype-Phenotype Association of Matrix Metalloproteinase-3 Polymorphism and Its Synergistic Effect With Smoking on the Occurrence of Acute Coronary Syndrome
AU - Liu, Ping-Yen
AU - Li, Yi-Heng
AU - Chan, Shih-Hung
AU - Lin, Li Jen
AU - Wu, Hua-Lin
AU - Shi, Guey Yueh
AU - Chen, Jyh Hong
PY - 2006/10/15
Y1 - 2006/10/15
N2 - Matrix metalloproteinase-3 (MMP-3) degrades the extracellular matrix and may contribute to the weakening of the plaque cap. To determine whether genotype-phenotype associations differed in different categories of acute coronary syndrome, we enrolled 650 consecutive Taiwanese patients diagnosed with acute coronary syndrome. Genotypic analysis was done on DNA using polymerase chain reaction and direct sequencing on the 5 adenines (5A)/6 adenines (6A; -1,171 bp) polymorphism in the MMP-3 gene promoter region. The frequency of the 5A polymorphism was higher in patients with acute coronary syndrome, especially in those with ST-elevation myocardial infarction (p <0.01). The number of 5A allele polymorphisms was strongly associated with more complex coronary angiography (diffuse score for 5A/5A vs 5A/6A vs 6A/6A, 6.6 ± 1.2 vs 5.3 ± 1.3 vs 4.6 ± 1.1, all p values <0.05 in subgroup analysis) and higher plasma MMP-3 activity in this acute coronary syndrome cohort (MMP-3 level for 6A/6A vs 5A/6A vs 5A/5A, 21.0 ± 2.2 vs 23.3 ± 2.1 vs 27.9 ± 2.2 ng/ml, all p values <0.05 in subgroup analysis). Multiple logistic regression analysis showed that this polymorphism, in addition to hypertension, diabetes, and a history of smoking, was an independent risk factor (odds ratio 2.2, 95% confidence interval 1.1 to 4.3, p = 0.02) for the occurrence of acute coronary syndrome. Further, carriers of this polymorphism who smoked had a significantly increased (20-fold) risk of acute coronary syndrome compared with nonsmoking noncarriers. In conclusion, the MMP-3 5A/6A polymorphism is significantly associated with the occurrence of acute coronary syndrome, MMP-3 activity, and severity of coronary atherosclerosis. There is a synergistic effect between smoking and this genetic risk factor for acute coronary syndrome.
AB - Matrix metalloproteinase-3 (MMP-3) degrades the extracellular matrix and may contribute to the weakening of the plaque cap. To determine whether genotype-phenotype associations differed in different categories of acute coronary syndrome, we enrolled 650 consecutive Taiwanese patients diagnosed with acute coronary syndrome. Genotypic analysis was done on DNA using polymerase chain reaction and direct sequencing on the 5 adenines (5A)/6 adenines (6A; -1,171 bp) polymorphism in the MMP-3 gene promoter region. The frequency of the 5A polymorphism was higher in patients with acute coronary syndrome, especially in those with ST-elevation myocardial infarction (p <0.01). The number of 5A allele polymorphisms was strongly associated with more complex coronary angiography (diffuse score for 5A/5A vs 5A/6A vs 6A/6A, 6.6 ± 1.2 vs 5.3 ± 1.3 vs 4.6 ± 1.1, all p values <0.05 in subgroup analysis) and higher plasma MMP-3 activity in this acute coronary syndrome cohort (MMP-3 level for 6A/6A vs 5A/6A vs 5A/5A, 21.0 ± 2.2 vs 23.3 ± 2.1 vs 27.9 ± 2.2 ng/ml, all p values <0.05 in subgroup analysis). Multiple logistic regression analysis showed that this polymorphism, in addition to hypertension, diabetes, and a history of smoking, was an independent risk factor (odds ratio 2.2, 95% confidence interval 1.1 to 4.3, p = 0.02) for the occurrence of acute coronary syndrome. Further, carriers of this polymorphism who smoked had a significantly increased (20-fold) risk of acute coronary syndrome compared with nonsmoking noncarriers. In conclusion, the MMP-3 5A/6A polymorphism is significantly associated with the occurrence of acute coronary syndrome, MMP-3 activity, and severity of coronary atherosclerosis. There is a synergistic effect between smoking and this genetic risk factor for acute coronary syndrome.
UR - http://www.scopus.com/inward/record.url?scp=33749240721&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33749240721&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2006.05.017
DO - 10.1016/j.amjcard.2006.05.017
M3 - Article
C2 - 17027562
AN - SCOPUS:33749240721
VL - 98
SP - 1012
EP - 1017
JO - American Journal of Cardiology
JF - American Journal of Cardiology
SN - 0002-9149
IS - 8
ER -